ARWR CIK: 879407

Arrowhead Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.41
FY23:
0.42
FY24:
0.70
FY25:
0.95
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.29
FY23:
0.35
FY24:
0.44
FY25:
0.43
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.71
FY22:
0.69
FY23:
0.77
FY24:
1.14
FY25:
1.39

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.14
FY23:
0.11
FY24:
0.10
FY25:
0.20
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.13
FY23:
0.37
FY24:
0.85
FY25:
0.69
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.40
FY23:
0.27
FY24:
0.19
FY25:
0.47
Total liabilities & equity
billions USD
FY21:
0.71
FY22:
–
FY23:
–
FY24:
–
FY25:
–

All amounts in billions USD Data sources:SEC EDGARTwelve Data